Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM402852
Substrate
n/a
Meas. Tech.
IRAK4 Kinase Assay
IC50
1.000±n/a nM
Citation
 Lim, JAltman, MDBrubaker, JDGibeau, CR Pyrrolotriazine inhibitors of IRAK4 activity US Patent  US10329295 Publication Date 6/25/2019 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM402852
Synonyms:
N-[3-(difluoromethyl)-1- methyl-1H-pyrazol-4-yl]- 2-{[(3R,5R)-5- fluoropiperidin-3- yl]amino}pyrrolo[2,1- f][1,2,4]triazine-7- carboxamide trifluoroacetate | US10329295, Example 165
Type:
Small organic molecule
Emp. Form.:
C17H19F3N8O
Mol. Mass.:
408.381
SMILES:
Cn1cc(NC(=O)c2ccc3cnc(N[C@H]4CNC[C@H](F)C4)nn23)c(n1)C(F)F |r|
Structure:
Search PDB for entries with ligand similarity: